Literature DB >> 1376365

Posttranslational side chain modification of a viral epitope results in diminished recognition by specific T cells.

J K Larson1, L Otvos, H C Ertl.   

Abstract

A stretch of 16 amino acid residues within the nominal phosphoprotein of rabies virus was shown to carry an immunodominant epitope for class I- and class II-restricted T cells. The nominal phosphoprotein of rabies virus is thought to be heterogeneously phosphorylated at multiple serine and threonine residues. The synthetic peptide that expressed the T-cell epitope contained a single serine residue corresponding to position 196 of the protein. Phosphorylation of this serine within the synthetic peptide caused a significant decrease of the antigenic potency of the peptide. A similar effect was seen if the serine was replaced by an alanine or if the peptide was glycosylated at its acidic residues. These data suggest that T-cell-mediated recognition of antigen presented by major histocompatibility complex class I- or II-positive cells is impaired not only by point mutations but also by posttranslational side chain modifications of residues within viral epitopes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376365      PMCID: PMC241202     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Reversed-phase high-performance liquid chromatographic separation of synthetic phosphopeptide isomers.

Authors:  L Otvos; I A Tangoren; K Wroblewski; M Hollosi; V M Lee
Journal:  J Chromatogr       Date:  1990-07-20

2.  Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule.

Authors:  G M Van Bleek; S G Nathenson
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

3.  T helper cell epitope of rabies virus nucleoprotein defined by tri- and tetrapeptides.

Authors:  H C Ertl; B Dietzschold; L Otvos
Journal:  Eur J Immunol       Date:  1991-01       Impact factor: 5.532

4.  Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells.

Authors:  O Rötzschke; K Falk; K Deres; H Schild; M Norda; J Metzger; G Jung; H G Rammensee
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

5.  Identification of an immunodominant epitope within the phosphoprotein of rabies virus that is recognized by both class I- and class II-restricted T cells.

Authors:  J K Larson; W H Wunner; L Otvos; H C Ertl
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

Review 6.  Probing T cell antigen recognition: use of synthetic peptides.

Authors:  D R Milich
Journal:  Pept Res       Date:  1990 Mar-Apr

7.  Nucleotide and deduced amino acid sequences of the nominal nonstructural phosphoprotein of the ERA, PM and CVS-11 strains of rabies virus.

Authors:  J K Larson; W H Wunner
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

Review 8.  Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids.

Authors:  G B Fields; R L Noble
Journal:  Int J Pept Protein Res       Date:  1990-03

Review 9.  Prediction of the secondary structure of proteins from their amino acid sequence.

Authors:  P Y Chou; G D Fasman
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1978

10.  Human T-cell clones recognize chemically synthesized peptides of influenza haemagglutinin.

Authors:  J R Lamb; D D Eckels; P Lake; J N Woody; N Green
Journal:  Nature       Date:  1982-11-04       Impact factor: 49.962

View more
  4 in total

1.  Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.

Authors:  Patrick R Harrington; Boyd Yount; Robert E Johnston; Nancy Davis; Christine Moe; Ralph S Baric
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Prediction of potential cytotoxic T lymphocyte epitopes of bovine herpesvirus 1 based on allele-specific peptide motifs and proteolytic cleavage specificities.

Authors:  N R Hegde; S Srikumaran
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

3.  Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy.

Authors:  Florence R Depontieu; Jie Qian; Angela L Zarling; Tracee L McMiller; Theresa M Salay; Andrew Norris; A Michelle English; Jeffrey Shabanowitz; Victor H Engelhard; Donald F Hunt; Suzanne L Topalian
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-06       Impact factor: 11.205

4.  Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo.

Authors:  A L Zarling; S B Ficarro; F M White; J Shabanowitz; D F Hunt; V H Engelhard
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.